Price Chart

DATE TIME TYPE PERIOD REPORTED
EPS
ESTIMATED
EPS
SURPRISE
10/25/2022 09:00 EST Earnings Call Q3 2022 -- -- --
10/24/2022 -- Results Q3 2022 -- 1.54 --
07/26/2022 09:00 EST Earnings Call Q2 2022 -- -- --
07/25/2022 -- Results Q2 2022 1.48 1.39 7.20%
04/26/2022 09:00 EST Earnings Call Q1 2022 -- -- --
04/25/2022 -- Results Q1 2022 1.71 1.31 30.36%
02/15/2022 09:00 EST Earnings Call Q4 2021 -- -- --
02/14/2022 -- Results Q4 2021 1.36 1.29 4.85%
*Estimated Date/Time

Earnings

Next Report Date 10/24/2022
EPS Estimate Upgrade
Last Actual EPS Upgrade

Loading chart...
Last Report Date 07/25/2022
Beat/Miss Upgrade
Return Since -1.01%
Last FQE 06/30/2022
Next FQE 09/30/2022

Profile

Edit
Medpace Holdings Inc is a clinical contract research organization. It is engaged in scientifically-driven outsourced clinical development services to the biotechnology, pharmaceutical, and medical device industries. It operates in North America, Europe, Africa, Middle East, Asia-Pacific and Latin America.
URL https://www.medpace.com
Investor Relations URL https://investor.medpace.com/
HQ State/Province Ohio
Sector Healthcare
Industry Diagnostics & Research
Equity Style Small Cap/Blend
Next Earnings Release Oct. 24, 2022
Last Earnings Release Jul. 25, 2022
Next Ex-Dividend Date N/A
Last Ex-Dividend Date N/A

Dividends

Dividend Per Share (TTM) --
2017
2018
2019
2020
2021
No data available
 
6.00%
4.00%
2.00%
 
Yield to Market 0.00
Yield to Sector 0.00
Yield to Industry 0.00
Last Dividend Amt. --
Dividend Frequency --
Last Ex-Dividend Date --
Yield (TTM) 0.00%
Forward Yield --
Payout Ratio 0.00%
Cash Payout Ratio 0.00%
Consistent Payer (5Y) No
Consistent Growth (5Y) No

Ownership

Insider Ownership Percentage Upgrade
Jul '20
Nov '20
Mar '21
 
80.00%
40.00%
10.00%
 

Short Interest

Short Interest Upgrade
Percent of Shares Outstanding Short Upgrade
Jul '20
Nov '20
Mar '21
 
80.00%
40.00%
10.00%
 

Total Returns Comparison

Edit comparables

Annual Total Returns Versus Peers

Edit comparables
Loading chart...
Name
2015
2016
2017
2018
2019
2020
2021
YTD
--
--
0.53%
45.97%
58.81%
65.60%
56.35%
-24.03%
1.38%
11.96%
21.83%
-4.38%
31.49%
18.40%
28.71%
-21.90%
8.35%
31.89%
9.16%
-13.84%
31.15%
14.04%
47.86%
-24.50%
13.97%
16.77%
24.56%
-7.55%
14.49%
21.51%
14.53%
-68.33%
-3.72%
15.23%
-1.33%
40.20%
22.42%
-7.07%
1.86%
17.11%
-16.74%
-42.70%
-65.09%
-66.67%
107.0%
68.93%
-67.85%
-87.16%
As of October 04, 2022.

Profile

Edit
Medpace Holdings Inc is a clinical contract research organization. It is engaged in scientifically-driven outsourced clinical development services to the biotechnology, pharmaceutical, and medical device industries. It operates in North America, Europe, Africa, Middle East, Asia-Pacific and Latin America.
URL https://www.medpace.com
Investor Relations URL https://investor.medpace.com/
HQ State/Province Ohio
Sector Healthcare
Industry Diagnostics & Research
Equity Style Small Cap/Blend
Next Earnings Release Oct. 24, 2022
Last Earnings Release Jul. 25, 2022
Next Ex-Dividend Date N/A
Last Ex-Dividend Date N/A

Ownership

Insider Ownership Percentage Upgrade
Jul '20
Nov '20
Mar '21
 
80.00%
40.00%
10.00%
 

Short Interest

Short Interest Upgrade
Percent of Shares Outstanding Short Upgrade
Jul '20
Nov '20
Mar '21
 
80.00%
40.00%
10.00%
 

Top Fund Holders

Symbol Dollars Invested % Weight
WAAEX 78.87M USD 3.74%
HELX 363730.0 USD 3.43%
WIGRX 74.26M USD 2.61%
PTH 5.168M USD 2.12%
JSMD 2.516M USD 1.51%
HTEC 1.469M USD 1.47%
FTHAX 82.67M USD 1.47%
DIGGX 52.19M USD 1.44%
RFG 3.666M USD 1.40%
TDB927 51.21M USD 1.13%
TQAAX 41.46M USD 0.62%
BFOR 341944.0 USD 0.27%

Top Portfolio Holders

0 of 0

Other Resources

Whale Wisdom 13F Filings
Seeking Alpha Call Transcripts
Morningstar Insider Trading
Nasdaq Institutional Ownership
Nasdaq Option Chain
SEC SEC Filings
Twitter MEDP Tweets